Results 31 to 40 of about 95,573 (296)

The Collocating Receptacle-Collecting Duct Carcinoma

Cell & Cellular Life Sciences Journal, 2023
Collecting duct carcinoma configures as an exceptionally discerned renal cell carcinoma contributing to < 1% of renal neoplasms and depicts an aggressive clinical course. Tumefaction is confined to renal medulla and is posited to arise from principal cells of distal collecting ducts of Bellini. Collecting duct carcinoma is additionally designated as
Anubha Bajaj
openaire   +2 more sources

Avelumab in metastatic collecting duct carcinoma of the kidney: a case report. [PDF]

J Med Case Rep, 2023
Background Collecting duct carcinoma (CDC) of the kidney is associated with an aggressive course, limited response to treatment, and poor prognosis.
Pyrgidis N, Sokolakis I, Haltmair G, Heller V, Hatzichristodoulou G.   +4 more
europepmc   +2 more sources

A Rare Case of Collecting Duct Carcinoma With Extensive Coagulative Necrosis. [PDF]

Cureus, 2023
Collecting duct carcinoma (CDC) is an aggressive renal malignancy with limited diagnostic and therapeutic consensus. We report a case of a 69-year-old male with CDC and extensive coagulative necrosis who presented with lower extremity swelling, abdominal
Colef R, Mescallado L, Kiran N, Wrzolek M, Khan S.   +4 more
europepmc   +2 more sources

Collecting Duct Carcinoma of the Kidney: A Single-Center Retrospective Study of 23 Cases. [PDF]

Technol Cancer Res Treat, 2023
Objective: To explore the clinical, imaging, pathologic features, treatment, and prognostic outcomes in 23 cases of collecting duct carcinoma (CDC) from a single center. Methods: The clinical and imaging findings, pathological features, treatment methods,
Tang C, Dong J, Chen H, Li P, Zhou Y, He H, Sheng Z, Qu L, Zhou W.   +8 more
europepmc   +2 more sources

Genomic profiling of collecting duct renal carcinoma [PDF]

Aging, 2016
Chintala, Sreenivasulu, Pili, Roberto
core   +3 more sources

A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. [PDF]

BMC Med Genomics, 2022
Background Renal collecting duct carcinoma (CDC) is a rare and lethal subtype of renal cell carcinoma (RCC). The genomic profile of the Chinese population with CDC remains unclear. In addition, clinical treatments are contradictory.
Zhang H, Lu X, Huang G, Hua M, Zhang W, Wang T, Huang L, Wang Z, Chen Q, Li J, Yang Q, Yang G.   +11 more
europepmc   +3 more sources

Renal collecting duct carcinoma: A case report and literature review

Asian Journal of Surgery, 2023
Xin Deng, Guifu Zhang, Haifeng Wang, Yigang Zuo   +3 more
doaj   +2 more sources

Impact of treatment modalities on prognosis of patients with metastatic renal collecting duct carcinoma. [PDF]

Sci Rep, 2022
Although patients with renal collecting duct carcinoma (CDC) benefit from surgery, the value of cytoreductive nephrectomy (CNx) for the prognosis of patients with metastatic CDC remains unclear.
Qian X, Wan J, Tan Y, Liu Z, Zhang Y.
europepmc   +2 more sources

Impact of Treatment Modalities on Prognosis in Patients With Renal Collecting Duct Carcinoma: A Population-Based Study. [PDF]

Front Oncol, 2022
Objective Renal collecting duct carcinoma (CDC) is an extremely rare disease with few studies, and the current understanding of its prognosis is limited.
Qian X, Xu J, Liu C, Zhong M, Hong S, Qian C, Zhu J, Zhang J, Wang S.   +8 more
europepmc   +2 more sources

Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report. [PDF]

Oncol Lett
Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful.
Nascimento de Assis TCF, Rapatoni L, Segato FN, Maciel Pontes BT, Muglia VF, Neto MM, Almeida Romao E.   +6 more
europepmc   +2 more sources